CLDI — Calidi Biotherapeutics Share News
0.000.00%
Last trade - 00:00Brief: Calidi Bio Announces Issuance Of New U.S. Patent Covering Novel Supernova Technology Platform
Brief: Calidi To Effect Reverse Stock Split
Brief: Calidi Biotherapeutics Presents CLD-101 Phase 1 Trial Update
Brief: Calidi Biotherapeutics Announces Pricing Of $6.1 Million Public Offering
U.S. RESEARCH ROUNDUP-Adobe, Microsoft, ServiceNow
Brief: Calidi Biotherapeutics And City Of Hope Announce Funding To Advance Cld-101 In Ovarian Cancer
Brief: Calidi Bio: To Highlight Novel Systemic Enveloped Oncolytic Virotherapy Platform at Conference
Brief: Calidi Biotherapeutics Announces The Appointment Of Three New Members To Its Scientific And Medical Advisory Board
Brief: Calidi Biotherapeutics Entered Into A Standby Equity Purchase Agreement
Brief: Calidi Biotherapeutics Announces Appointment Of David Lapré To Board Of Directors
Brief: Calidi Biotherapeutics Announces Issuance Of New US Patent for Novel Supernova Technology Platform
Brief: Calidi Biotherapeutics Entered Into Employment Agreement With Andrew Jackson To Serve As CFO
Brief: Calidi Biotherapeutics To Present New Preclinical Data Highlighting Cell-Based Virotherapy (Supernova) Platform Technology